| Control group (n = 46) | mPCR group (n = 46) | p value |
---|---|---|---|
Age (m) | 3.1 (1.1–22.1) | 2.8 (1.2–24.5) |  |
Sex: male | 27/46 (58.7%) | 26/46 (56.5%) | 1.000 |
Weight (kg) | 6.1 (4.3–11.6) | 6.0 (4.4–11.9) | 0.903 |
LOS (d) | 5.0 (5.0–6.0) | 5.0 (4.0–7.0) | 0.384 |
ICU | 10/46 (21.7%) | 11/46 (23.9%) | 1.000 |
CNS infections | 5/46 (10.9%) | 14/46 (30.4%) | 0.038 |
CRP (mg/dl) | 0.6 (0.1–1.7) | 0.8 (0.3–2.2)1 | 0.267 |
Leucocytes (G/L) | 8.4 (6.3–14.0) | 9.0 (7.2–14.1)2 | 0.577 |
IL-6 (pg/ml) | 30.0 (14.9–63.7)3 | 50.1 (10.2–106.5)4 | 0.401 |
CSF samples analyzed | 36/46 (78.3%) | 33/46 (71.7%) | Â |
Cell count (/μl) | 2.0 (1.0–5.5) | 2.0 (1.0–6.0) | 0.522 |
Protein (mg/dl) | 34.4 (19.4–53.7) | 33.3 (17.6–56.2) | 0.936 |
Glucose (mg/dl) | 56.6 (52.0–69.6) | 56.7 (50.5–66.0) | 0.893 |